[1]
Organisation Mondiale de la Sante. Trypanosomiase humaine africaine (maladie du
sommeil) [En ligne].2014 [consulté le 20 mars 2014]. Disponible : http://www.who.int/mediacentre/factsheets/fs259/fr/
[2] Forde RM. Some clinical notes on a European patient
in whose blood a trypanosome was observed. J Trop Med 1902, 5:261-263.
[3] Dutton JE. Preliminary note upon a trypanosome occurring in the
blood of man. Thompson Yates Lab Rep 1902, 4:455-468.
[4] Castellani A. On the discovery of a species of Trypanosoma in the
cerebro-spinal fluid of ases of sleeping
sickness. Proc R Soc Lond 1903, 71:501-508.
[5] D. Bruce. Note on the discovery
of a New Trypanosoma, Proceedings of the Royal Physical Society of Edinburgh,
IXIX, 1902, p. 496 ;
[6] MULLIGAN H.W. (1970) The Ahican Trypanosomiases. Eds Allen &
Unwin LTD, London
[7] AUSTEN E.E., 1903 A monograph of the Tsetse flies (genus Glossina,
Westwood). British Museum, 327 p.
[8] Bruce D. Preliminary report on the tsetse fly disease or nagana in
Zululand Durban: Bennett and Davis; 1895.
[9] World Health Organization: African trypanosomiasis (sleeping
sickness). 2006 [http://www.who.int/mediacentre/factsheets/fs259/en/]. World
Health Organ Fact Sheet.
[10] Hide G: History of sleeping sickness in East Africa. Clin Microbiol
Rev 1999, 12:112-125.
[11] WHO/CDS/CSR/ISR/2000.1: Chapter 8 – African trypanosomiasis. In WHO
Report on Global Surveillance of Epidemic-prone Infectious Diseases World Health
Organization; 2000:95-106.
[12] de Raadt P: The history of
sleeping sickness. 2005 [http://www.who.int/ trypanosomiasis_african/country/history/en/print.html].
World Health Org
[13] Cox FEG: History of sleeping sickness (African trypanosomiasis). Infect
Dis Clin N Am 2004, 18:231-245.
[14] Winkle S: Geißeln der Menschheit. Kulturgeschichte der Seuchen
Düsseldorf: Artemis & Winkler; 2005.
[15] Bray PG, Barrett MP, Ward SA, de Koning HP: Pentamidine uptake and
resistance in pathogenic protozoa: past, present and future. Trends Parasitol
2003, 19:232-239
[16] Meyskens FL Jr, Gerner EW: Development of difluoromethylornithine
(DFMO) as a chemoprevention agent. Clin Cancer Res 1999, 5:945-951.
[17] Hoare CA. The Trypanosomes of Mammals. A Zoological Monograph. Oxford
and Edinburgh: Blackwell Scientific Publications; 1972.
[18] LAVEISSIERE (c), PENCHENIER
(L). Manuel de lutte contre la maladie du sommeil. Paris : IRD Éditions ; 2005 p.
48.
[19] Kennedy P.G. Clinical features, diagnosis, and treatment of human
African trypanosomiasis (sleeping sickness). Lancet Neurol., 2013, 12, 186-194.
[20] Brun R, Blum J, Chappuis F, Burri C. Human African trypanosomiasis.
Lancet 2010; 375: 148–59.
[21] LAVEISSIERE (c), PENCHENIER (L). Manuel de lutte contre
la maladie du sommeil. Paris : IRD Éditions ; 2005 p. 50.
[22] Vickerman K, Tetley L, Hendry KA, Turner CM. Biology of African
trypanosomes in the tsetse fly. Biol Cell. 1988;64(2):109–119
[23] Van Den Abbeele J, Claes Y, Van Bockstaele D, Le Ray D, Coosemans
M. Trypanosoma brucei spp. Development in the tse-tse fly: characterization of
the post-mesocyclic stage in the foregut and the proboscis. Parasitology 1999 ; 118 : 469-478
[24]
LAVEISSIERE (c), PENCHENIER (L). Manuel
de lutte contre la maladie du sommeil. Paris
: IRD Éditions ; 2005 p. 52.
[25] Welburn SC, Maudlin I. Tse-tse trypanosome interactions: rites of
passage. Parasitol Today 1999 ; 15 : 399-403
[26]
LAVEISSIERE (c), PENCHENIER (L). Manuel
de lutte contre la maladie du sommeil. Paris : IRD Éditions ; 2005 p. 61.
[27]
LAVEISSIERE (c), PENCHENIER (L). Manuel
de lutte contre la maladie du sommeil. Paris : IRD Éditions ; 2005 p. 62.
[28] Vanhollebeke, B. et Pays, E., 2010. The trypanolytic factor of
human serum: many ways to enter the parasite, a single way to kill. Molecular
Microbiology, 76 (4): 806-814.
[29] Pays, E. et Vanhollebeke, B., 2008. Mutual self-defence: the
trypanolytic factor story. Microbes and Infection, 10 (9): 985-989.
[30] Genovese, G., Friedman, D.J., Ross, M.D., Lecordier, L., Uzureau,
P., Freedman, B.I., Bowden, D.W., Langefeld, C.D., Oleksyk, T.K., Knob, A.U.,
Bernhardy, A., Hicks, P.J., Appel, G.B., Nelson, G.W., Vanhollebeke, B.,
Winkler, C.A., Kopp, J.B., Pays, E., and Pollak, M.R. (2010) Association of
trypanolytic apoL1 variants with kidney disease in African-Americans. Science
329, 841-845.
[31] Leslie, M., 2010. Kidney disease is parasite-slaying protein's
downside. Science, 329 (5989): 263.
[32] Pierrick Uzureau, Sophie Uzureau, Laurence Lecordier, Frédéric
Fontaine, Patricia Tebabi, Fabrice Homblé, Axelle Grélard, Vanessa Zhendre,
Derek P. Nolan, Laurence Lins, Jean-Marc Crowet, Annette Pays, Cécile Felu,
Philippe Poelvoorde, Benoit Vanhollebeke, Soren K. Moestrup, Jeppe Lyngsø, Jan
Skov Pedersen, Jeremy C. Mottram, Erick J. Dufourc, David Pérez-Morga &
Etienne Pays Mechanism of Trypanosoma brucei gambiense resistance to human
serum Nature 21 aout 2013, 501, 430-434 doi:10.1038/nature12516. Disponible à l’URL: http://www.nature.com/nature/journal/vaop/ncurrent/full/nature12516.html
[33] Pays E, Vanhollebeke B.
Human innate immunity against African trypanosomes. Curr Opin
Immunol.2009;21(5):493–498.
[34] Mehlitz D, Zillmann U,
Scott C, et al. Epidemiological studies on the animal reservoir of Gambiense
sleeping sickness. Part III. Characterization of trypanozoon stocks by
isoenzymes and sensitivity to human serum. Tropen Med Parasitol 1982 ; 33 :
113-8.
[35] Nkinin S.W., Njiokou F., Penchenier L., Grébaut P., Simo G.,
Ngassam P., Herder S., 2001 - Characterisation of Trypanosoma brucei s.l. by
isoenzymes in the central african sub-region. ISCTRC, OAU/STRC, 26th Meeting,
Ouagadougou
[36] Warren Photographic. Tsetse Fly (Glossina morsitans) excreting
fluid after blood meal [En ligne] c2012-2014 [consulté le 30 avril 2014]. Disponible : http://www.warrenphotographic.co.uk/16224-tsetse-fly-excreting-fluid-after-sucking-blood
[37] Warren Photographic. Tsetse Fly (Glossina morsitans) sucking blood
from a human arm. [En ligne]
c2012-2014 [consulté le 30 avril 2014]. Disponible : http://www.warrenphotographic.co.uk/06348-tsetse-fly-biting
[38] KETILE D.S. (1995) Medical an Veterinary Entomology. 2nd Edition, Eds CAB International.
[39]
LAVEISSIERE (c), PENCHENIER (L). Manuel
de lutte contre la maladie du sommeil. Paris : IRD Éditions ; 2000 p. 55.
[40]
LAVEISSIERE (c), GREBAUT (P), PENCHENIER
(L), HERDER (S). Les glossines vectrices de la Maladie du Sommeil. Paris : IRD Éditions ; 2000 p. 35.
[41] FORD (J.), KATONDO (K.M.),
1973 - Maps of tsetse fly (Glossina) distribution in Africa, 1973, according to
sub-generic groups on scale of 1 :5,000 000
(plus a set of 9 maps in colour). Bull.
Anim. Hlth. Production, 25, 187-1 93.
[42] CHALLIER
(A.), 1973 - Ecologie de Glossina palpalis gambiensis Vanderplank 1949 (Diptera
; Muscidae) en savane d'Afrique occidentale. Mém. ORSTOM, n° 64, 274p.
[43] CUISANCE
D. (1995) Les grandes endémies parasitaires à transmission vectorielle.
Glossines et trypanosomes. Cours de DEA de Parasitologie, Montpellier, France.
[44] PHELPS
(R.J.) & VALE (G.A.), 1978 - Studies on populations of Glossina morsitans
morsitans and G. pallidipes (Diptera ; Glossinidae) in Rhodesia. J. appl.
Ent., 15, 743-76
[45] CUISANCE
(D.) & FEVRIER (J.), 1983 - Etude sur le pouvoir de dispersion des
glossines.Rapport IEMVT./CRTA, 82p.
[46] WEITZ (B.), 1963 - The feeding habits of Glossina: Bull. Wld. Hlth Org., 28, 71 1-729.
[47] GOUTEUX
(J.P.), LAVEISSIERE (C.) & BOREHAM (P.F.L.), 1982 - Ecologie des glossines
en secteur pré-forestier de Côte d'Ivoire. 2. Les préférences trophiques de
Glossina palpalis s.1. Cah. ORSTOM, Sér. Ent. méd. Parasitol., XX, 3-1 8.
[48] DE LA ROCQUE (S), CUISANCE (D), La
Tsé-tsé : une mouche singulière et dangereuse. Insecte.2005 ; N°136 : 27-31
[49]
LAVEISSIERE (C.) & SANE (B.), 1994 - Régulateur de croissance et
piégeage pour la lutte contre Glossina palpalis palpalis en Côte d'Ivoire :
essai sur le terrain de l'OMS 3019
(Pyriproxyfen, Sumitomo). Insect Sci. Applic., 15, 105-1 10.
[50] D'ALMEIDA
(J.F.), 1985 - Contribution à I'étude du piégeage de Glossina longipalpis
Wiedemann 1830 en zone de savane guinéenne de Côte d'Ivoire. Mémoire de DEA/CEMV/Bouaké,
n°11, 72p.
[51]
LAVEISSIERE (C.), DYEMKOUMA (A.), KIENOU (J.P.) & TRAORE (T.), 1976 -
Enquête entomologique et épidémiologique dans le foyer de trypanosomiase
humaine de Kolda (Sénégal). Rapport OCCGE/Centre Muraz, no 13/ENT/76, 18p.
[52] CHALLIER
(A.), 1973 - La capacité vectorielle des glossines. Rapport OCCGE/Centre Muraz,
no 5.416/Doc. Tech. OCCGE, 22p.
[53] MEDA
(A.H.), LAVEISSIERE (C.), DE MUYNCK (A.), DOUA (F.) et DIALLO (P.B.), 1993 - Les facteurs de risque de la
Trypanosomiase humaine africaine dans les foyers endémiques de Côte d'Ivoire. Médecine tropicale, 53, 83-92.
[54] World Health Organization. Report of a WHO meeting on elimination
of African trypanosomiasis (Trypanosoma brucei gambiense), 3-5 December
2012, Geneva, Switzerland. WHO/HTM/NTD/IDM 2013.4 apps.who.int/ iris/bitstream/10665/79689/1/WHO_HTM_NTD_IDM_2013.4_eng.pdf(accessed 27 May 2013)
[55] Brun R, Blum J, Chappuis F, Burri C. Human African trypanosomiasis.
Lancet 2010; 375: 148–59.
[56] Kennedy PGE. The fatal sleep. Edinburgh: Luath Press, 2010.
[57] Picozzi K, Fèvre EM, Odiit M, et al. Sleeping sickness in Uganda: a
thin line between two fatal diseases. BMJ 2005; 331: 1238–41.
[58] Cecchi G et al. Towards the Atlas of human African trypanosomiasis.
International Journal of Health Geographics, 2009, 8:155.
[59] Simarro PP, Cecchi G, Franco JR, et al. Estimating and mapping the
population at risk of sleeping sickness. PLoS Negl Trop Dis. 2012;6(10):e1859
[60] MWANGI DM, HOPKINS J, LUCKINS AG - Trypanosoma congolense infection
in sheep: Cellular phenotypes in lymph and lymph nodes associated with skin
reactions. J Comp Pathol 1996 ; 114 : 51-61.
[61] OLSSON T, BAKHIETM, EDLUND C et al. - Bidirectional activating
signals between Trypanosoma brucei and CD8+ T cells:A trypanosome-released
factor triggers interferon-gamma production that stimulates parasite growth.
Eur J Immunol 1991 ; 21 : 2447-54.
[62] OKOMO-ASSOUMOU MC, DAULOUEDE S, LEMESRE JL et al. - Correlation of
high serum levels of tumor necrosis factor-alpha with disease severity in human
African trypanosomiasis. Am J Trop Med Hyg 1995 ; 53 : 539-43.
[63] BUGUETA, BANZET S, BOUTEILLE B et al. - NO a cornerstone in
sleeping sickness: Voltammetric assessment in animal and man. In « MORAVEC J,
TAKEDA N, SINGAL PK -Adaptation Biology and Medicine, vol 3, chapter 23».
Narosha Publishing House ed, New Dehli, India, 2002, pp 221-9.
[64] VINCENDEAU P, BOUTEILLE B - Immunology and immunopathology of
African trypanosomiasis. An Acad Bras Cienc 2006 ; 78 : 645-65.
[65] KOFFI M, SOLANO P, DENIZOT M et al. - Aparasitemic serological
suspects in Trypanosoma brucei gambiense human African trypanosomiasis: a
potential human reservoir of parasites? Acta Trop 2006 ; 98 : 183-8.
[66] DUBOIS ME, DEMICK KP, MANSFIELD JM - Trypanosomes expressing a
mosaic variant surface glycoprotein coat escape early detection by the immune
system. Infect Immun 2005 ; 73 : 2690-7.
[67] DUMAS M, BISSER S - Clinical aspects of human African
trypanosomiasis. In «DUMAS M, BOUTEILLE B, BUGUET A - Progress in human African
Trypanosomiasis, sleeping sickness». Springer-Verlag, Paris (France), 1999, pp.
215-23.
[68] KENNEDY PG - Human African trypanosomiasis of the CNS: Current
issues and challenges. J Clin Invest 2004 ; 113 : 496-504.
[69] BUGUET A, BERT J, TAPIE P et al. - - Sleep-wake cycle in human
African trypanosomiasis. J Clin Neurophysiol 1993 ; 10 : 190-6.
[70] KOTEN JW, DE RAADT P - Myocarditis in Trypanosoma rhodesiense
infections. Trans R Soc Trop Med Hyg 1969 ; 63 : 485-9.
[71] BRAAKMAN HM, VAN DE MOLENGRAFT FJ, HUBERTWW, BOERMAN DH - Lethal
African trypanosomiasis in a traveller : MRI and neuropathology. Neurology 2006
; 66 : 1094-6.
[72] CARPENTER MB, SUTIN J - Human neuroanatomy. Eight edition.Williams
andWilkins ed, 1983, 872 p.
[73] DHIB-JALBUT S, MCFARLIN DE, MCFARLAND HF - Measles virus-polypeptide
specificity of the cytotoxic T-lymphocyte response in multiple sclerosis. J
Neuroimmunol 1989 ; 21 : 205-212.
[74] PRINEAS JW - Multiple sclerosis: Presence of lymphatic capillaries
and lymphoid tissue in the brain and spinal cord. Science 1979 ; 203 : 1123-5.
[75] WIDNER H, MOLLER G, JOHANSSON BB - Immune response in deep cervical
lymph nodes and spleen in the mouse after antigen deposition in different
intracerebral sites. Scand J Immunol 1988 ; 28 : 563-71.
[76] KIVISAKK P, MAHAD DJ, CALLAHANMK et al. - Expression of CCR7 in
multiple sclerosis: Implications for CNS immunity. Ann Neurol 2004 ; 55 :
627-8.
[77] HICKEYWF, KIMURA H - Graft-vs.-host disease elicits expression of
class I and class II histocompatibility antigens and the presence of scattered
T lymphocytes in rat central nervous system. Proc Natl Acad Sci USA 1987 ; 84 :
2082-6.
[78] BAILEY SL, CARPENTIER PA, MCMAHON EJ et al. - Innate and adaptive
immune responses of the central nervous system. Crit Rev Immunol 2006 ; 26 :
149-88.
[79] MCMAHON EJ, BAILEY SL, MILLER SD - CNS dendritic cells: Critical
participants in CNS inflammation? Neurochem Int 2006 ; 49 :195-203.
[80] WEBB AA, MUIR GD - The blood-brain barrier and its role in
inflammation. J Vet Intern Med 2000 ; 14 : 399-411.
[81] GRAB DJ, NIKOLSKAIA O, KIMYV et al. -African trypanosome
interactions with an in vitro model of the human blood-brain barrier. J
Parasitol 2004 ; 90 : 970-9.
[82] MULENGA C, MHLANGA JD, KRISTENSSON K, ROBERTSON B - Trypanosoma
brucei brucei crosses the blood-brain barrier while tight junction proteins are
preserved in a rat chronic disease model. Neuropathol Appl Neurobiol 2001 ; 27
: 77-85.
[83] SCHULTZBERG M, AMBATSIS M, SAMUELSSON EB et al. - Spread of
Trypanosoma brucei to the nervous system: Early attack on circumventricular
organs and sensory ganglia. J Neurosci Res 1988 ; 21 : 56-61.
[84] PHILIP KA, DASCOMBE MJ, FRASER PA, PENTREATH VW - Blood-brain
barrier damage in experimental African trypanosomiasis. Ann Trop Med Parasitol
1994 ; 88 : 607-16.
[85] KEITAM, BOUTEILLE B, ENANGA B et al. - Trypanosoma brucei brucei:A
long-term model of humanAfrican trypanosomiasis in mice, meningoencephalitis,
astrocytosis, and neurological disorders. Exp Parasitol 1997 ; 85 : 183-92.
[86] TIZARD I, NIELSEN KH, SEED JR, HALL JE - Biologically active
products fromAfrican Trypanosomes. Microbiol Rev 1978 ; 42 : 664-81.
[87] PENTREATHVW, ALAFIATAYO RA, BARCLAY GR et al. - Endotoxin
antibodies inAfrican sleeping sickness. Parasitology 1997 ; 114 : 361-65.
[88] KEITAM, VINCENDEAU P, BUGUETA et al. - Inducible nitric oxide
synthase and nitrotyrosine in the central nervous system of mice chronically
infected with Trypanosoma brucei brucei. Exp Parasitol 2000 ; 95 :19-27.
[89] LONSDALE-ECCLES JD, GRAB DJ - Trypanosome hydrolases and the
blood-brain barrier. Trends Parasitol 2002 ; 18 : 17-9.
[90] NIKOLSKAIA OV, DE A LIMA AP, KIMYV et al. - Blood-brain barrier
traversal by African trypanosomes requires calcium signalling induced by
parasite cysteine protease. J Clin Invest 2006 ; 116 : 2739-47.
[91] VISWAMBHARAN H, SEEBECK T,YANG Z - Enhanced endothelial nitric
oxide-synthase activity in mice infected with Trypanosoma brucei. Int J
Parasitol 2003 ; 33 : 1099-104.
[92] GIRARD M, BISSER S, COURTIOUX B et al. - In vitro induction of
microglial and endothelial cell apoptosis by cerebrospinal fluids from patients
with human African trypanosomiasis. Int J Parasitol 2003 ; 33 : 713-20.
[93] STILES JK,WHITTAKER J, SARFO BY et al. - Trypanosome apoptotic
factor mediates apoptosis in human brain vascular endothelial cells. Mol
Biochem Parasitol 2004 ; 133 : 229-40.
[94] MASOCHA W, ROBERTSON B, ROTTENBERG ME et al. - Cerebral vessel
laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the
blood-brain barrier. J Clin Invest 2004 ; 114 : 689-94.
[95] PENTREATH VW, OWOLABI AO, DOUA F - Survival of Trypanosoma brucei
brucei in cerebrospinal fluid. Ann Trop Med Parasitol 1992 ; 86 : 29-34.
[96] ENANGA B, BURCHMORE RJ, STEWART ML, BARRETT MP - Sleeping sickness
and the brain. Cell Mol Life Sci 2002 ; 59 : 845-58.
[97] BRENIER-PINCHARTMP, PELLOUX H, DEROUICH-GUERGOUR D,AMBROISE-THOMAS
P - Chemokines in host-protozoan-parasite interactions. Trends Parasitol 2001 ;
17 : 292-6.
[98] LEJON V, LARDON J, KENIS G et al. - Interleukin (IL)-6, IL-8 and
IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness
patients before and after treatment. Trans R Soc Trop Med Hyg 2002 ; 96 :
329-33.
[99] COURTIOUX B, BODA C, VATUNGA G et al. - A link between chemokine
levels and disease severity in human African trypanosomiasis. Int. J.
Parasitol. 2006 ; 36 : 1057-65.
[100] AMEVIGBE MD, JAUBERTEAU-MARCHAN MO, BOUTEILLE B et al. - Human
African trypanosomiasis: Presence of antibodies to galactocerebrosides. Am J
Trop Med Hyg 1992 ; 47 : 652-62.
[101] OKOMO-ASSOUMOUMC, GEFFARDM, DAULOUEDE S et al. - Circulating
antibodies directed against tryptophan-like epitopes in sera of patients with
human African trypanosomiasis. Am J Trop Med Hyg 1995 ; 52 : 461-7.
[102] AYED Z, BRINDEL I, BOUTEILLE B et al. - Detection and
characterization of autoantibodies directed against neurofilament proteins in
human African trypanosomiasis. Am J Trop Med Hyg 1997 ; 57 : 1-6.
[103] LEJON V, ROSENGREN LE, BUSCHER P et al. - Detection of light
subunit neurofilament and glial fibrillary acidic protein in cerebrospinal
fluid of Trypanosoma brucei gambiense-infected patients. Am J Trop Med Hyg 1999
; 60 : 94-8.
[104] PENTREATH VW - Trypanosomiasis and the nervous system. Pathology
and immunology. Trans R Soc Trop Med Hyg 1995 ; 89 : 9-15.
[105] GHAFFAR(A). BLOOD AND TISSUE PROTOZOA[En ligne]. University of
South Carolina. [cité le
15/04/2010] .Disponible à l’URL : http://pathmicro.med.sc.edu/parasitology/blood-proto.htm
[106] Institut de recherche pour le
développement (IRD). Les Symptômes (Phase lymphatico-sanguine) [En ligne].
Institut de recherche pour le développement (IRD).11 mai 2011 [consulté le 5
mars 2014]. Disponible à l’URL : http://www.sleeping-sickness.ird.fr/index.htm
[107] Association Française des Enseignants de
Parasitologie et Mycologie (ANOFEL).Trypanosomose Humaine Africaine (Maladie du
sommeil) [En ligne].Université Médicale Virtuelle Francophone,2011 [cité le
30/04/2012]. Disponible à l’URL : http://umvf.univ-nantes.fr/parasitologie/enseignement/
maladiesommeil/ site/html/4_2.html
[108] Integrated Vector Management Human African Trypanosomiasis. [En ligne]. Integrated Vector Management,2010. Disponible à
l’URL : http://www.ivmproject.net/about/index.cfm?fuseaction=static&label=hat
[109] Magnus E, Vervoort T, Van Meirvenne N. A cardagglutination test
with stained trypanosomes (CATT) for the serological diagnosis of T. gambiense
trypanosomiasis. Ann Soc Belg
Méd Trop 1978 ; 58 : 169-176
[110] Louis
F.J., Kohagne Tongue L., Eboo Eyenza V. Simarro P.P. Organisarion d'une
campagne de dépistage de la Trypanosomiase humaine africaine à Trynasoma brucei
gambensae . Med. Trop., 2008, 68, 11-16.
[111] Woo PT. The haematocrit centrifuge technique for the diagnosis of
african trypanosomiasis. Acta Trop 1970;27: 384-386.
[112] Lanham S, Godfrey DG. Isolation of salivarian trypanosomes from
man and other mammals using DEAEcellulose. Exp Parasitol 1970 ; 28 : 521-534
[113] Lumsden WH, Kimber DD, Dukes P, Haller L, Stangellini A, Duvallet
G. Field diagnosis of sleeping sickness in the Ivory Coast. I. Comparison of
the miniature anion exchanger/centrifugation technique with other
protozoological methods. Trans R Soc Trop Med Hyg 1981;75: 242-249
[114] Aerts D, Truc P, Penchenier L, Claes Y, Le Ray D. A kit for in
vitro isolation of trypanosomes in the ®eld: ®rst ®eld trial with sleeping
sickness patients. Trans R Soc Trop Med Hyg 1992 ; 86 : 394-395
[115] Mugasa, C. M., Adams, E. R., Boer, K. R., Dyserinck, H. C.,
Buscher, P., Schallig, H. D. et Leeflang, M. M., 2012. Diagnostic accuracy of
molecular amplification tests for human African trypanosomiasis: systematic
review. PLoS Neglected Tropical Diseases, 6 (1): e1438.
[116] BOUTEILLE B, OUKEM O, BISSER S, DUMAS M - Treatment perspectives
for human African trypanosomiasis. Fundam Clin Pharmacol 2003 ; 17 :171-81.
[117] LEJONV, ROBAYS J, N'SIESI FX et al. - Treatment Failure Related to
intrathecal immunoglobulin M (IgM)
synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with
hemolymphatic-stage sleeping sickness. Clin Vaccine Immunol 2007 ; 14 : 732-7.
[118] DUMAS M, BISSER S - Clinical aspects of human African
trypanosomiasis. In «DUMAS M, BOUTEILLE B, BUGUET A - Progress in human African
Trypanosomiasis, sleeping sickness». Springer-Verlag, Paris (France), 1999, pp.
215-23.
[119] WORLD HEALTH ORGAN TECH REP SER - Control and surveillance
ofAfrican trypanosomiasis. World Report of aWHO expert committee 1998; 881 :
1-113.
[120] CATTAND P, MIEZAN BT, DE RAADT P - Human African trypanosomiasis:
Use of double centrifugation of cerebrospinal fluid to detect trypanosomes.
Bull World Health Organ 1988 ; 66 : 83-86.
[121] MIEZAN TW, MEDA HA, DOUA F et al. - Single centrifugation of
cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive
detection of trypanosomes. Trans R Soc Trop Med Hyg 2000 ; 94 : 293.
[122] MIEZAN TW, MEDA HA, DOUA F et al. -Assessment of central nervous
system involvement in gambiense trypanosomiasis: Value of the cerebrospinal
white cell count. Trop Med Int Health 1998 ; 3 : 571-5.
[123] Kennedy PGE. Diagnosing central nervous system trypanosomiasis:
two stage or not to stage? Trans R Soc Trop Med Hyg 2008; 102: 306–07.
[124] KJELDSBERG CR, KNIGHT JA - Cerebrospinal fluid. In « JOHNSON KD -
Body fluids» American Society of Clinical Pathologists ed, 1993, pp 65-157.
[125] KYAMBADDE JW, ENYARU JC, MATOVU E et al. - Detection of
trypanosomes in suspected sleeping sickness patients in Uganda using the
polymerase chain reaction. Bull World Health Organ 2000 ; 78 : 119-24.
[126] JAMONNEAU V, SOLANO P, GARCIA A et al. - Stage determination and
therapeutic decision in human African trypanosomiasis: Value of polymerase
chain reaction and immunoglobulin M quantification on the cerebrospinal fluid
of sleeping sickness patients in Cote d'Ivoire. Trop Med Int Health 2003 ; 8 :
589-94.
[127] BISSER S, LEJON V, PREUX PM et al. - Blood-cerebrospinal fluid
barrier and intrathecal immunoglobulins compared to field diagnosis of central
nervous system involvement in sleeping sickness. J Neurol Sci 2002 ; 193 :
127-35.
[128] BISSER S, OUWE-MISSI-OUKEM-BOYER ON, TOURE FS et al. - Harbouring
in the brain: A focus on immune evasion mechanisms and their deleterious
effects in malaria and human African trypanosomiasis. Int J Parasitol 2006 ; 36 : 529-40.
[129] Hainard,
A., Tiberti, N., Robin, X., Lejon, V., Ngoyi, D. M., Matovu, E., Enyaru, J. C.,
Fouda, C., Ndung'u, J. M., Lisacek, F., Muller, M., Turck, N. et Sanchez, J.
C., 2009. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human
African trypanosomiasis patients. PLoS
Neglected Tropical Diseases, 3 (6): e459
[130] Hainard,
A., Tiberti, N., Robin, X., Ngoyi, D. M., Matovu, E., Enyaru, J. C., Muller,
M., Turck, N., Ndung'u, J. M., Lejon, V. et Sanchez, J. C., 2011. Matrix metalloproteinase-9 and
intercellular adhesion molecule 1 are powerful staging markers for human
African trypanosomiasis. Tropical Medicine & International Health, 16 (1):
119-126.
[131] Tiberti, N., Hainard, A., Lejon, V., Courtioux, B., Matovu, E.,
Enyaru, J. C., Robin, X., Turck, N., Kristensson, K., Ngoyi, D. M., Vatunga, G.
M., Krishna, S., Buscher, P., Bisser, S., Ndung'u, J. M. et Sanchez, J. C.,
2012. Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage
of Trypanosoma brucei gambiense sleeping sickness. PLoS One, 7 (7): e40909.
[132] SIMARROPP, LOUIS FJ, JANNINJ – Sleeping sickness, the forgotten
disease:The consequences in the field and a proposal for the action.XXVIIth
ISTRC, Pretoria,Afrique du Sud, 29/09-03/10/2003.
[133] SIMARRO
PP, LOUIS FJ, JANNIN J – Lutte contre la maladie du sommeil : réflexions sur la
prise de decisions. Premier Congrès International sur la mouche tsétsé et les
trypanosomoses, Brazzaville, Congo, 23-25 mars 2004.
[134] NOIREAU F, LEMESRE JL, NZOUKOUDIMY – Serodiagnosis of sleeping
sickness in the Republic of the Congo: Comparison of indirect immunofluorescent
antibody test and card agglutination test. Trans R Soc Trop Med Hyg 1988 ; 82 :
237-40.
[135] BAFORT JM, SCHUTTE CH, GATHIRAMV – Specificity of the Testryp CATT
card agglutination test in a non-sleeping-sickness area ofAfrica. S Afr Med J
1986; 69 : 541-2.
[136] Wéry M. Drugs used in the treatment of sleeping sickness (human
african trypanosomiasis: HAT). Int J
Antimicrob Agents 1994;4:227-238
[137]
LAVEISSIERE (c), PENCHENIER (L). Manuel
de lutte contre la maladie du sommeil. Paris
: IRD Éditions ; 2005 p. 52.
[138] Collège
des universitaires des Maladies Infectieuses et Tropicales (CMIT). e-Pilly TROP
Maladies infectieuses tropicales [En ligne]. Paris : collège des
universitaires des Maladies Infectieuses et Tropicales (CMIT) ; 2012.[consulté
le 5 mars 2014] Disponible: http://www.epopi.fr/?page=fiche&id=883&cat_id=1412
[139] Bronner U, Doua F, Ericsson O, Gustafsson LL, Miézan TW, Laïs M,
Rombo L. Pentamidine concentrations in plasma, whole blood and cerebrospinal
¯uid during treatment of Trypanosoma
gambiense infection in Côte-d'Ivoire. Trans R Soc Trop Med Hyg 1991 ; 85 :
608-611
[140] Friedheim EA. Mel B in the treatment of human trypanosomiasis. Am
J Trop Med Hyg 1949 ; 29 : 173-180
[141] Pépin J, Milord F. African trypanosomiasis and druginduced
encephalopathy: risk factors and pathogenesis. Trans
R Soc Trop Med Hyg 1991 ; 85 : 222-224
[142]
OMS,Comité d'experts. La trypanosomiaseafricaine : lutte et surveillance.
Genève : OMS, Série rapport technique, 1998 : n° 881
[143] Edwards
RW, Rodick CL, Waed SA, Avadzo K, Orme ML, Breckenbridge AM.Determination of
suraminin plasmaby high performance liquid chromatography. J Chromatogr 1985 ; 343 : 224-228
[144] Klecker RW, Collins JM. Quanti®cation of suramin by reverse-phase
ion paving high performance liquid chromatography. J Liquid Chromatogr
1985;8:1685-1696
[145] Baker, N.; de Koning, H. P.; Mäser, P.; Horn, D. Trends Parasitol.
2013, 29, 110-118.
[146] Baker, N.; Glover, L.; Munday, J. C.; Aguinaga Andrés, D.;
Barrett, M. P.; de Koning, H. P.; Horn, D. Proc. Natl. Acad. Sci. USA 2012, 109, 10996-11001.
[147] Barrett, M. P., Vincent, I. M., Burchmore, R. J., Kazibwe, A. J.
et Matovu, E., 2011. Drug resistance in human African trypanosomiasis. [Chimiorésistance dans la trypanosomose humaine africaine.] Future
Microbiology, 6 (9): 1037-1047.
[148] Torreele,
E.; Bourdin Trunz, B.; Tweats, D.; Kaiser, M.; Brun, R.; Mazué, G.; Bray, M.
A.; Pécoul, B. PLoS Negl. Trop. Dis. 2010, 4, e923.
[149] Barrett, M. P.; Croft, S. L. Brit. Med. Bull. 2012, 104, 175-196
[150] Kaiser, M., Bray, M. A., Cal, M., Bourdin Trunz, B., Torreele, E.
et Brun, R., 2011. Antitrypanosomal
activity of fexinidazole, a new oral nitroimidazole drug candidate for
treatment of sleeping sickness. Antimicrobial Agents & Chemotherapy, 55
(12): 5602-5608.
[151] Jacobs, R. T., Nare, B., Wring, S. A., Orr, M. D., Chen, D.,
Sligar, J. M., Jenks, M. X., Noe, R. A., Bowling, T. S., Mercer, L. T.,
Rewerts, C., Gaukel, E., Owens, J., Parham, R., Randolph, R., Beaudet, B.,
Bacchi, C. J., Yarlett, N., Plattner, J. J., Freund, Y., Ding, C., Akama, T.,
Zhang, Y. K., Brun, R., Kaiser, M., Scandale, I. et Don, R., 2011. SCYX-7158,
an orally-active benzoxaborole for the treatment of stage 2 human African
trypanosomiasis. PLoS Neglected Tropical Diseases, 5 (6): e1151.
[152] Tiberti, N., Lejon, V., Hainard, A., Courtioux, B., Robin, X.,
Turck, N., Kristensson, K., Matovu, E., Enyaru, J. C., Mumba Ngoyi, D.,
Krishna, S., Bisser, S., Ndung'u, J. M., Buscher, P. et Sanchez, J. C., 2013.
Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in
patients affected by Trypanosoma brucei gambiense sleeping sickness. PLoS Neglected Tropical Diseases, 7 (2): e2088.
[153] Bouyer(J),
Desquesnes(M), Kaboré(I), Dia(M), Gilles(J), Yoni(W), Cuisance(D). Le piégeage
des insectes vecteurs. CIRDES ; mars 2005 , 20 :1-12
[154] QUINLAN (R.J.) & GATEHOUSE (A.G.), 1981 - Characteristics and
implications of knockdown of the tsetse flies G. m. morsitans by deltamethrin. Pestic. Sci., 12, 439-442
[155]
LAVEISSIERE (C.), COURET (D.) et TRAORE (T.), 1985 - Tests d'efficacité et de
rémanence d'insecticides utilisés en imprégnation sur tissus pour Ia lutte par
piégeage contre les glossines. 1. Protocole expérimental. L'effet knockdown des
pyréthrinoides. Cah ORSTOM, sér Ent. méd. et Parasitol., XXIIIl 61-67.
